article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Adverse events were mostly mild and resolved spontaneously. A 2017 literature review by the National Academy of Sciences, Engineering, and Medicine concluded , “There is conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults.”

article thumbnail

Academic Cannabis Conference sets presenter schedule

Illinois News Joint

The Academic Cannabis Conference , produced by News Joint Events , is pleased to announce its full presenter lineup and schedule. at the Garden Grove Event Center in Carbondale on May 4. Sharma’s studies aims to offer strategic insights to inform cultivation practices and optimize cannabinoid production. 12:30 p.m. –

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Review: Butterstuff Infused Prerolls by Ozone

Illinois News Joint

As a staple sample at cannabis events for more than a year, Ozone has been ahead of the recent explosion of infused preroll options with its Reserve Live Resin infused two-packs. This pack of infused prerolls tested at 3.061% THC,19.291% THCa, and 23.15% total cannabinoids. Visually there was no indication of the live resin infusion.

Indica 95
article thumbnail

Review: Granddaddy Purple Diamond Pod by Rove

Illinois News Joint

total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. This pod tested at 1% THCa, 92.8% THC, and 96.7% For more Illinois News Joint reviews, visit here.

Vaping 92
article thumbnail

Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company

Cannabis Law Report

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. million of secured convertible debentures in Hyasynth (the “Debentures”).

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, 0.59, 95% CI [0.36–0.97]),

Safety 52
article thumbnail

Juva Life Launches Preclinical Comparative Study to Evaluate Anti-Inflammatory Properties of Candidate JUVA-019 in Conjunction With Other Well-Known Cannabinoids

Cannabis Law Report

Cannabis and Life Sciences Company Initiates Internal Study Comparing Anti-Inflammatory Properties of Candidate JUVA-019 When Combined With Cannabinoids Such as THC and CBD. November 30, 2021 04:00 ET | Source: Juva Life Inc. VANCOUVER, British Columbia, Nov. 30, 2021 (GLOBE NEWSWIRE) — Juva Life Inc.